SMi Group’s 2nd Annual Lyophilisation USA conference returns to the USA on April 27-28 in 2016.
The thriving biopharmaceutical industry and rise in contract services are driving lyophilization in an exponential rate. In addition, the rise of combination products and innovative drug delivery devices enable innovative drug formulations which can only be stable in solid format. As a result, the global lyophilization market is estimated to grow from a value of US $2.bn in 2013 to US$4.8 bn by 2020.*
While companies are still dedicating research efforts on drying technologies, commerciality of scaling up and homogeneity of product quality remain top concerns amongst pharmaceutical companies.
The SMi 2nd annual Lyophilization USA conference returns to New Jersey in 2016 to go one step further, exploring and assessing how QbD can accelerate drug development and lyophilization programme, industrialization and scale-up for economic cycle, as well as overcoming regulatory uncertainties.
Join us today to gain practical insights for optimal commercialization of your lyophilization program for a replenished drug pipeline!
Electronic Access - Single User Fulfilled By Publisher
Electronic Access - Global site License Fulfilled By Publisher